David Alan Campbell sold $1.3M of Janux Therapeutics (JANX)

Executed Nov 25 2024, disclosed Nov 27 2024, 2 days later.

Value, as filed

$1.3M

25,000 sh across 2 lots

Executed

Nov 25 2024

the trade date, as filed

Disclosed

Nov 27 2024

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

DC David Alan Campbell President and CEO profile →

David Alan Campbell (President and CEO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in JANX. The largest single filing was $111K of JANX (8,072 sh × $13.73, as filed), executed Jan 2.

The name

JANX JANX JANX · 18 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by David Alan Campbell in JANX

JANXSALE Janux Therapeutics, Inc. $111K
8,072 sh × $13.73
Exec Jan 2
Filed Jan 2 · 5:30 PM ET JANXSALE Janux Therapeutics, Inc. $300K
5,000 sh × $60.00
Exec Jan 7 2025
Filed Jan 8 2025 · 5:30 PM ET JANXSALE Janux Therapeutics, Inc. $1.4M
25,000 sh × $56.19
Exec Dec 24 2024
Filed Dec 27 2024 · 5:30 PM ET JANXSALE Janux Therapeutics, Inc. $1.0M
15,000 sh × $67.00
Exec Dec 3 2024
Filed Dec 3 2024 · 5:30 PM ET JANXSALE Janux Therapeutics, Inc. $1.3M
25,000 sh across 2 lots
Exec Oct 28 2024
Filed Oct 30 2024 · 5:30 PM ET JANXSALE Janux Therapeutics, Inc. $1.1M
24,205 sh across 2 lots
Exec Sep 27 2024
Filed Sep 27 2024 · 5:30 PM ET